MEDIFAST INC (MED)

Currency in USD
10.83
-0.05(-0.42%)
Real-time Data·
MED is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.7610.89
52 wk Range
9.2215.46
Key Statistics
Prev. Close
10.88
Open
10.8
Day's Range
10.76-10.89
52 wk Range
9.22-15.46
Volume
73.24K
Average Vol. (3m)
259.59K
1-Year Change
-12.5202%
Book Value / Share
19.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.00
Upside
+10.80%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

MEDIFAST INC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients’ long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body’s metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

MEDIFAST INC Earnings Call Summary for Q4/2025

  • Medifast reported Q4 2025 EPS of -$1.65, missing forecasts by 266.67%, while revenue slightly exceeded expectations at $75.1 million despite a 36.9% YoY decline.
  • Active earning coaches decreased by 40.6%, contributing to operational challenges as gross profit margin fell 470 basis points to 69.4%.
  • The company issued 2026 revenue guidance of $270-$300 million with expected losses per share between $1.55 and $2.75.
  • CEO Dan Chard affirmed no strategy pivot while management focuses on metabolic health products and restructuring efforts targeting $30 million in savings.
  • Profitability improvements are projected for Q4 2026, with opportunities identified in serving clients transitioning off GLP-1 medications.
Last Updated: 02/17/2026, 05:26 PM
Read Full Transcript
MEDIFAST investor slides for Q4/2025
Medifast Q4 2025 slides
Last Update: Feb 17, 2026
See full investor slides

Compare MED to Peers and Sector

Metrics to compare
MED
Peers
Sector
Relationship
P/E Ratio
−6.0x−8.1x12.0x
PEG Ratio
0.010.110.03
Price / Book
0.6x1.8x1.5x
Price / LTM Sales
0.3x0.8x0.9x
Upside (Analyst Target)
10.3%8.9%21.8%
Fair Value Upside
Unlock13.2%11.6%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 12.00
(+10.80% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stephens
Hold12.00+10.80%15.00MaintainFeb 19, 2026

Earnings

Latest Release
Feb 17, 2026
EPS / Forecast
-1.65 / -0.45
Revenue / Forecast
75.1M / 73.8M
EPS Revisions
Last 90 days

MED Income Statement

People Also Watch

230.97
FDS
+3.32%
110.16
GPC
+0.23%
57.93
APTV
-1.94%
60.76
CTSH
+1.20%
886.68
SNDK
-6.12%

FAQ

What Is the MEDIFAST (MED) Stock Price Today?

The MEDIFAST stock price today is 10.83 USD.

What Stock Exchange Does MEDIFAST Trade On?

MEDIFAST is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for MEDIFAST?

The stock symbol for MEDIFAST is "MED."

What Is the MEDIFAST Market Cap?

As of today, MEDIFAST market cap is 111.70M USD.

What Is MEDIFAST's Earnings Per Share (TTM)?

The MEDIFAST EPS (TTM) is -1.70.

When Is the Next MEDIFAST Earnings Date?

MEDIFAST will release its next earnings report on May 04, 2026.

From a Technical Analysis Perspective, Is MED a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has MEDIFAST Stock Split?

MEDIFAST has split 0 times.

How Many Employees Does MEDIFAST Have?

MEDIFAST has 380 employees.

What is the current trading status of MEDIFAST (MED)?

As of Apr 15, 2026, MEDIFAST (MED) is trading at a price of 10.83 USD, with a previous close of 10.88 USD. The stock has fluctuated within a day range of 10.76 USD to 10.89 USD, while its 52-week range spans from 9.22 USD to 15.46 USD.

What Is MEDIFAST (MED) Price Target According to Analysts?

The average 12-month price target for MEDIFAST is 12.00 USD, with a high estimate of 12 USD and a low estimate of 12 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +10.80% Upside potential.

What Is the MED Premarket Price?

MED's last pre-market stock price is 10.95 USD. The pre-market share volume is 10.00, and the stock has decreased by 0.07, or 0.64%.

What Is the MED After Hours Price?

MED's last after hours stock price is 10.88 USD, the stock has decreased by 0.01, or 0.09%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.